GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 10 shares, a growth of ? from the June 30th total of 0 shares. Based on an average daily trading volume, of 53,818 shares, the short-interest ratio is currently 0.0 days.
GB Sciences Price Performance
GBLX remained flat at $0.00 on Friday. 5,300 shares of the company were exchanged, compared to its average volume of 33,665. GB Sciences has a 52-week low of $0.00 and a 52-week high of $0.01.
About GB Sciences
GB Sciences, Inc is a biotechnology company focused on the research, development and commercialization of cannabinoid-based medicines. Leveraging both botanical and synthetic approaches, the company aims to create novel therapies targeting oncology, neurology and inflammatory diseases. Through its proprietary drug discovery platform, GB Sciences seeks to identify and advance lead compounds that harness the therapeutic potential of cannabinoids while ensuring high standards of quality and safety.
The company operates a cGMP-compliant research and manufacturing facility in Irvine, California, and maintains partnerships to support cultivation and extraction activities in select geographies.
See Also
- Five stocks we like better than GB Sciences
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
